At a glance
- Originator Bristol-Myers Squibb
- Class Anti-inflammatories; Antibacterials; Quinolones; Small molecules
- Mechanism of Action 5-lipoxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 09 Dec 1996 New profile
- 09 Dec 1996 No-Development-Reported for Inflammation in Japan (Unknown route)